Ovarian Cancer and Us - best viewed in FIREFOX

Google Search: this blog, links from posts and the web.....

Loading...

Saturday, December 05, 2009

This test can spare women from chemo. But they can't get it here - The Globe and Mail



This test can spare women from chemo. But they can't get it here - The Globe and Mail

My response: some of the public's opinions which, as usual, were way off target to the original focus of the article: It's always a great transformation of opinion when those without a cancer diagnosis are diagnosed. It's very nice to know there are so many who believe in each paying for their own healthcare except...that's nice. But, envision your neighbour, your family member, your friend who cannot. Envision if it is your neighbour's child. Nice that we seem to have come to such a one-person self-centerness that we cannot see beyond the small picture of one.

Questioning a Cancer Drug That Costs $30,000 a Month - NYTimes.com



Questioning a Cancer Drug That Costs $30,000 a Month - NYTimes.com

2009 Cochrane review: Opioids for the management of breakthrough (episodic) pain in cancer patients



Opioids for the management of breakthrough (episodic) pain in cancer patients

Response: Does Morphine Stimulate Cancer Growth? | GeriPal - A Geriatrics and Palliative Care Blog



Does Morphine Stimulate Cancer Growth? | GeriPal - A Geriatrics and Palliative Care Blog

Response to the dialogues:
Sandi Pniauskas said...

While the media and pharma are often criticized in situations such as this, there is the communication factor - good or bad. The value to patients of harm vs benefit is that the information is available and sufficient enough for patients to question, research and also take the information for discussion to their professional caregivers. The e-patient communities welcome dialogues but not in an exclusive setting which is absent their participation.

Neurontin: PRC: Journals Aided in Marketing of Gabapentin - in Meeting Coverage, PRC from MedPage Today



Medical News: PRC: Journals Aided in Marketing of Gabapentin - in Meeting Coverage, PRC from MedPage Today

Medical News: PRC: Study Finds Less Ghost Authorship, Critics Ask Why - in Meeting Coverage, PRC from MedPage Today



Medical News: PRC: Study Finds Less Ghost Authorship, Critics Ask Why - in Meeting Coverage, PRC from MedPage Today

Absolute benefits of medical therapies in phase III clinical trials for breast and colorectal cancer




Diaphragmatic surgery during primary debulking in 89 patients with stage IIIB-IV epithelial ovarian cancer.



The clinical outcome of epithelial ovarian cancer patients with apparently isolated lymph node recurrence: A multicenter retrospective Italian study.